Trial Profile
A phase I/IIa study of MS1819 for the treatment of chronic pancreatitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Adrulipase alfa (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- 15 Sep 2015 New trial record